The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis

Masahiro Tojo, Tadao Oikawa, Yoshiyuki Morikawa, Naoya Yamashita, Satoshi Iwata, Yoshitake Satoh, Juhei Hanada, Ryuichiro Tanaka

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

We studied the effects of Bifidobacterium breve on Campylobacter enteritis. Patients with Campylobacter enteritis were divided into three groups (I. Erythromycin recipients; II. B. breve recipients; III. control) and studied with regard to the duration of diarrhea and carriage of Campylobacter jejuni in the stools. Additional studies were performed to observe the effects of B. breve on fecal flora. The results showed that there were no significant differences in the duration of diarrhea among the three groups. Comparison of the duration of C. jejuni carriage in the stools was as follows: KIKIII (P<0.01). Microbiological study of fecal flora demonstrated that the number of bifidobacterium was decreased in Campylobacter enteritis compared to the control, and an increase in the number of bifidobacterium could be recognized after the administration of B. breve. B. breve was useful in eradicating C. jejuni from the stools and restoring the normal intestinal flora in Campylobacter enteritis, although if was not effective in shortening the duration of diarrhea.

Original languageEnglish
Pages (from-to)160-167
Number of pages8
JournalPediatrics International
Volume29
Issue number1
DOIs
Publication statusPublished - 1987

Fingerprint

Campylobacter
Enteritis
Campylobacter jejuni
Diarrhea
Bifidobacterium
Erythromycin
Bifidobacterium breve

Keywords

  • Bifidobacterium breve
  • Campylobacter enteritis
  • Erythromycin
  • Intestinal flora

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Tojo, M., Oikawa, T., Morikawa, Y., Yamashita, N., Iwata, S., Satoh, Y., ... Tanaka, R. (1987). The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis. Pediatrics International, 29(1), 160-167. https://doi.org/10.1111/j.1442-200X.1987.tb00024.x

The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis. / Tojo, Masahiro; Oikawa, Tadao; Morikawa, Yoshiyuki; Yamashita, Naoya; Iwata, Satoshi; Satoh, Yoshitake; Hanada, Juhei; Tanaka, Ryuichiro.

In: Pediatrics International, Vol. 29, No. 1, 1987, p. 160-167.

Research output: Contribution to journalArticle

Tojo, M, Oikawa, T, Morikawa, Y, Yamashita, N, Iwata, S, Satoh, Y, Hanada, J & Tanaka, R 1987, 'The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis', Pediatrics International, vol. 29, no. 1, pp. 160-167. https://doi.org/10.1111/j.1442-200X.1987.tb00024.x
Tojo, Masahiro ; Oikawa, Tadao ; Morikawa, Yoshiyuki ; Yamashita, Naoya ; Iwata, Satoshi ; Satoh, Yoshitake ; Hanada, Juhei ; Tanaka, Ryuichiro. / The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis. In: Pediatrics International. 1987 ; Vol. 29, No. 1. pp. 160-167.
@article{06e8a3eee0824bcb8e49c8462656833f,
title = "The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis",
abstract = "We studied the effects of Bifidobacterium breve on Campylobacter enteritis. Patients with Campylobacter enteritis were divided into three groups (I. Erythromycin recipients; II. B. breve recipients; III. control) and studied with regard to the duration of diarrhea and carriage of Campylobacter jejuni in the stools. Additional studies were performed to observe the effects of B. breve on fecal flora. The results showed that there were no significant differences in the duration of diarrhea among the three groups. Comparison of the duration of C. jejuni carriage in the stools was as follows: KIKIII (P<0.01). Microbiological study of fecal flora demonstrated that the number of bifidobacterium was decreased in Campylobacter enteritis compared to the control, and an increase in the number of bifidobacterium could be recognized after the administration of B. breve. B. breve was useful in eradicating C. jejuni from the stools and restoring the normal intestinal flora in Campylobacter enteritis, although if was not effective in shortening the duration of diarrhea.",
keywords = "Bifidobacterium breve, Campylobacter enteritis, Erythromycin, Intestinal flora",
author = "Masahiro Tojo and Tadao Oikawa and Yoshiyuki Morikawa and Naoya Yamashita and Satoshi Iwata and Yoshitake Satoh and Juhei Hanada and Ryuichiro Tanaka",
year = "1987",
doi = "10.1111/j.1442-200X.1987.tb00024.x",
language = "English",
volume = "29",
pages = "160--167",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis

AU - Tojo, Masahiro

AU - Oikawa, Tadao

AU - Morikawa, Yoshiyuki

AU - Yamashita, Naoya

AU - Iwata, Satoshi

AU - Satoh, Yoshitake

AU - Hanada, Juhei

AU - Tanaka, Ryuichiro

PY - 1987

Y1 - 1987

N2 - We studied the effects of Bifidobacterium breve on Campylobacter enteritis. Patients with Campylobacter enteritis were divided into three groups (I. Erythromycin recipients; II. B. breve recipients; III. control) and studied with regard to the duration of diarrhea and carriage of Campylobacter jejuni in the stools. Additional studies were performed to observe the effects of B. breve on fecal flora. The results showed that there were no significant differences in the duration of diarrhea among the three groups. Comparison of the duration of C. jejuni carriage in the stools was as follows: KIKIII (P<0.01). Microbiological study of fecal flora demonstrated that the number of bifidobacterium was decreased in Campylobacter enteritis compared to the control, and an increase in the number of bifidobacterium could be recognized after the administration of B. breve. B. breve was useful in eradicating C. jejuni from the stools and restoring the normal intestinal flora in Campylobacter enteritis, although if was not effective in shortening the duration of diarrhea.

AB - We studied the effects of Bifidobacterium breve on Campylobacter enteritis. Patients with Campylobacter enteritis were divided into three groups (I. Erythromycin recipients; II. B. breve recipients; III. control) and studied with regard to the duration of diarrhea and carriage of Campylobacter jejuni in the stools. Additional studies were performed to observe the effects of B. breve on fecal flora. The results showed that there were no significant differences in the duration of diarrhea among the three groups. Comparison of the duration of C. jejuni carriage in the stools was as follows: KIKIII (P<0.01). Microbiological study of fecal flora demonstrated that the number of bifidobacterium was decreased in Campylobacter enteritis compared to the control, and an increase in the number of bifidobacterium could be recognized after the administration of B. breve. B. breve was useful in eradicating C. jejuni from the stools and restoring the normal intestinal flora in Campylobacter enteritis, although if was not effective in shortening the duration of diarrhea.

KW - Bifidobacterium breve

KW - Campylobacter enteritis

KW - Erythromycin

KW - Intestinal flora

UR - http://www.scopus.com/inward/record.url?scp=84994998005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994998005&partnerID=8YFLogxK

U2 - 10.1111/j.1442-200X.1987.tb00024.x

DO - 10.1111/j.1442-200X.1987.tb00024.x

M3 - Article

AN - SCOPUS:84994998005

VL - 29

SP - 160

EP - 167

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 1

ER -